At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
Latest Information Update: 14 Dec 2020
At a glance
- Drugs Bamlanivimab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms UNITED
- 04 Dec 2020 Planned number of patients changed from 7500 to 500000, according to an Eli Lilly and Company media release.
- 04 Dec 2020 According to an Eli Lilly and Company media release, the company along with UnitedHealth Group today announced a partnership to conduct this study.
- 26 Nov 2020 New trial record